Keyphrases
AIDS/HIV
29%
BK Polyomavirus (BKPyV)
8%
CD8+ T Cells
7%
Cellular Immune Response
6%
Central Nervous System
10%
Cerebrospinal Fluid
13%
Clinical Outcomes
6%
COVID-19
22%
Cytotoxic T Lymphocytes
6%
Encephalopathy
10%
Epitope
5%
Glial Cells
7%
Granule Cell Neuronopathy
5%
HIV Patients
6%
Human Immunodeficiency Virus Infection
6%
Human Immunodeficiency Virus Type 1 (HIV-1)
5%
Immune Reconstitution
12%
Immunosuppressed
6%
Infected Patients
6%
JC Polyomavirus (JCPyV)
14%
JC Virus
66%
JC Virus Granule Cell Neuronopathy
5%
Long COVID
11%
Lymphotropic
8%
Multiple Sclerosis
10%
Multiple Sclerosis Treatment
6%
Natalizumab
11%
Neuro-PASC
12%
Neurologic
5%
Neurologic Symptoms
6%
Neurological Manifestations
12%
New-onset Seizure
8%
Non-hospitalized
8%
Opportunistic Infections
5%
Polyomavirus
6%
Post-acute Sequelae of SARS-CoV-2 Infection
8%
Progressive multifocal Leukoencephalopathy
100%
Regulatory Region
8%
Seizure
8%
Simian Virus 40 (SV40)
6%
Survivors
6%
T Cells
12%
T-cell Leukemia
8%
Virus
9%
Virus DNA
6%
Virus Type
7%
Virus-specific
8%
Virus-specific Cytotoxic T Lymphocytes
6%
Zambia
9%
Zambians
13%
Immunology and Microbiology
Adoptive Immunity
7%
BK Virus
8%
Capsid
5%
CD4
6%
CD8
5%
Central Nervous System
12%
Cerebrospinal Fluid
12%
Cytotoxic T Cell
13%
Cytotoxic T-Cell
10%
DNA Virus
10%
Epitope
7%
Granule Cell
11%
Human Immunodeficiency Virus
33%
Human Immunodeficiency Virus 1
5%
Immune Reconstitution Inflammatory Syndrome
8%
JC Virus
73%
Magnetic Resonance Imaging
5%
Multiple Sclerosis
10%
Natalizumab
10%
Polyomavirus
7%
Regulatory Region
7%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
T Cell
15%
Virus
10%
Virus Type
7%
Medicine and Dentistry
Brain Disease
5%
Central Nervous System
7%
Cerebrospinal Fluid
8%
COVID-19
17%
Diseases
12%
Epileptic Seizure
13%
Human Immunodeficiency Virus
38%
Human Immunodeficiency Virus Infection
5%
Immune Reconstitution Inflammatory Syndrome
5%
Infection
14%
JC Virus
22%
Multiple Sclerosis
5%
Neurologic Disease
15%
Polyomavirus
5%
Postcovid Syndrome
7%
Progressive Multifocal Leukoencephalopathy
42%
Sequela
7%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Virus DNA
5%